Indications & Usage
Directions: FOR ORAL USE ONLY.
Myristica Argentum
FDA Label NDC 48951-7204
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy Inc for the product Myristica Argentum (NDC 48951-7204). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications & usage, dosage & administration, otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, warnings, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration
Dissolve pellets under the tongue 3-4
times daily. Ages 12 and older: 10 pellets.
Ages 2-11: 5 pellets. Under age 2: Consult
a doctor.
Otc - Active Ingredient
Active Ingredients: Myristica seb. (Juice from the bark of Myristica sebifera) 4X, Kalium bichromicum (Potassium dichromate) 6X, Tunica mucosa nasi (Bovine nasal mucosa) 7X, Argentum nitricum (Silver nitrate) 20X
Inactive Ingredient
Inactive Ingredients: Sucrose
"prepared using rhythmical processes"
Otc - Purpose
Use: Temporary relief of sinus pain.
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
Warnings
Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Contains sugar. Diabetics and persons intolerant of sucrose (sugar): Consult a doctor before use. Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing.
Otc - Questions
Questions? Call 866.642.2858
Uriel, East Troy, WI 53120
shopuriel.com Lot:
* Please review the disclaimer below.
